Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes.

On the basis of both 125I-labeled plasminogen activator binding analysis and transmission electron microscopy studies of the interaction of a plasminogen activator/gold complex with cell membranes, we have found that human keratinocytes have specific receptors for human urokinase-type plasminogen activator distributed on the cell surface as singlets, or as small or large clusters. The use in binding experiments of the purified A chain of urokinase-plasminogen activator and of anti-A chain monoclonal antibodies has indicated that cell receptors are specific for a sequence present on the A chain, as previously reported for other cells. The interaction of both the native molecule and the purified A chain with such receptors stimulates mobilization of keratinocytes in an in vitro cell model system (Boyden chamber), when present in the lower compartment of the migration apparatus in nanomolar concentrations. Preincubation of chemoattractants with a monoclonal antibody which prevents receptor/ligand interaction also prevents plasminogen activator-induced cell migration. These data suggest that, under the conditions used in this in vitro model system, the plasminogen activator-dependent mobilization of keratinocytes depends on the interaction of the ligand with free receptors on the cell surface, and is independent of plasmin generation.

[1]  L. Magnelli,et al.  Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. , 1988, Experimental cell research.

[2]  P. Jensen,et al.  Epidermal plasminogen activator is abnormal in cutaneous lesions. , 1988, The Journal of investigative dermatology.

[3]  K. Hashimoto,et al.  Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor. , 1988, The Journal of investigative dermatology.

[4]  V Ottevanger,et al.  Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. , 1988, The Journal of investigative dermatology.

[5]  E. Plow,et al.  Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis , 1988 .

[6]  F. Blasi.  Surface Receptors for Urokinase Plasminogen Activator , 1988 .

[7]  L. Orci,et al.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells , 1987, The Journal of cell biology.

[8]  P. Gudewicz,et al.  Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. , 1987, Biochemical and biophysical research communications.

[9]  G. Dini,et al.  Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells , 1987, British journal of haematology.

[10]  P. Jensen,et al.  Migrating keratinocytes express urokinase-type plasminogen activator. , 1987, The Journal of investigative dermatology.

[11]  F. Blasi,et al.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors , 1987, The Journal of cell biology.

[12]  L. Liotta,et al.  Plasminogen Activators (Urokinase) Mediate Neovascularization: Possible Role in Tumor Angiogenesis , 1986, Seminars in thrombosis and hemostasis.

[13]  E. Appella,et al.  Autocrine saturation of pro-urokinase receptors on human A431 cells , 1986, Cell.

[14]  G. Dini,et al.  The Mr 17500 region of the A chain of urokinase is required for interaction with a specific receptor in A431 cells. , 1986, Biochimica et biophysica acta.

[15]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[16]  P. Andreasen,et al.  Plasminogen activator in psoriatic scales is of the tissue‐type PA as identified by monoclonal antibodies , 1985, The British journal of dermatology.

[17]  J. Slot,et al.  A new method of preparing gold probes for multiple-labeling cytochemistry. , 1985, European journal of cell biology.

[18]  G. Dini,et al.  Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts. , 1985, Cancer research.

[19]  S. Zigmond,et al.  Asymmetric distribution of the chemotactic peptide receptor on polymorphonuclear leukocytes , 1984, The Journal of cell biology.

[20]  K. Robbins,et al.  A functionally active heavy chain derived from human high molecular weight urokinase. , 1983, The Journal of biological chemistry.

[21]  R. Isseroff,et al.  Plasminogen is present in the basal layer of the epidermis. , 1983, The Journal of investigative dermatology.

[22]  R. Isseroff,et al.  Plasminogen activator in differentiating mouse keratinocytes. , 1983, Journal of Investigative Dermatology.

[23]  R. Langer,et al.  Plasminogen activator (urokinase) causes vascularization of the cornea. , 1982, Investigative ophthalmology & visual science.

[24]  H Green,et al.  Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[26]  K. Robbins,et al.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.

[27]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[28]  M. Cubellis,et al.  The receptor for urokinase‐plasminogen activator , 1986, Journal of cellular biochemistry.

[29]  P. Gullino,et al.  Interaction of gangliosides with fibronectin in the mobilization of capillary endothelium. Possible influence on the growth of metastasis. , 1986, Invasion & metastasis.

[30]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[31]  P. Verde,et al.  Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Bendayan.  Enzyme-gold electron microscopic cytochemistry: A new affinity approach for the ultrastructural localization of macromolecules , 1984 .